These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 25901047)

  • 1. Prognostic significance of depression in blacks with heart failure: insights from Heart Failure: a Controlled Trial Investigating Outcomes of Exercise Training.
    Mentz RJ; Babyak MA; Bittner V; Fleg JL; Keteyian SJ; Swank AM; Piña IL; Kraus WE; Whellan DJ; O'Connor CM; Blumenthal JA;
    Circ Heart Fail; 2015 May; 8(3):497-503. PubMed ID: 25901047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of exercise training on depressive symptoms in patients with chronic heart failure: the HF-ACTION randomized trial.
    Blumenthal JA; Babyak MA; O'Connor C; Keteyian S; Landzberg J; Howlett J; Kraus W; Gottlieb S; Blackburn G; Swank A; Whellan DJ
    JAMA; 2012 Aug; 308(5):465-74. PubMed ID: 22851113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychosocial Factors, Exercise Adherence, and Outcomes in Heart Failure Patients: Insights From Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION).
    Cooper LB; Mentz RJ; Sun JL; Schulte PJ; Fleg JL; Cooper LS; Piña IL; Leifer ES; Kraus WE; Whellan DJ; Keteyian SJ; O'Connor CM
    Circ Heart Fail; 2015 Nov; 8(6):1044-51. PubMed ID: 26578668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial.
    O'Connor CM; Whellan DJ; Lee KL; Keteyian SJ; Cooper LS; Ellis SJ; Leifer ES; Kraus WE; Kitzman DW; Blumenthal JA; Rendall DS; Miller NH; Fleg JL; Schulman KA; McKelvie RS; Zannad F; Piña IL;
    JAMA; 2009 Apr; 301(14):1439-50. PubMed ID: 19351941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Race, exercise training, and outcomes in chronic heart failure: findings from Heart Failure - a Controlled Trial Investigating Outcomes in Exercise TraiNing (HF-ACTION).
    Mentz RJ; Bittner V; Schulte PJ; Fleg JL; Piña IL; Keteyian SJ; Moe G; Nigam A; Swank AM; Onwuanyi AE; Fitz-Gerald M; Kao A; Ellis SJ; Kraus WE; Whellan DJ; O'Connor CM
    Am Heart J; 2013 Sep; 166(3):488-95. PubMed ID: 24016498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aerobic exercise training and general health status in ambulatory heart failure patients with a reduced ejection fraction-Findings from the Heart Failure and A Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION)trial.
    Ambrosy AP; Cerbin LP; DeVore AD; Greene SJ; Kraus WE; O'Connor CM; Piña IL; Whellan DJ; Wojdyla D; Wu A; Mentz RJ
    Am Heart J; 2017 Apr; 186():130-138. PubMed ID: 28454828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalent digoxin use and subsequent risk of death or hospitalization in ambulatory heart failure patients with a reduced ejection fraction-Findings from the Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION) randomized controlled trial.
    Ambrosy AP; Bhatt AS; Stebbins AL; Wruck LM; Fudim M; Greene SJ; Kraus WE; O'Connor CM; Piña IL; Whellan DJ; Mentz RJ
    Am Heart J; 2018 May; 199():97-104. PubMed ID: 29754673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anemia and associated clinical outcomes in patients with heart failure due to reduced left ventricular systolic function.
    McCullough PA; Barnard D; Clare R; Ellis SJ; Fleg JL; Fonarow GC; Franklin BA; Kilpatrick RD; Kitzman DW; O'Connor CM; Piña IL; Thadani U; Thohan V; Whellan DJ;
    Clin Cardiol; 2013 Oct; 36(10):611-20. PubMed ID: 23929781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relation of serum uric acid levels and outcomes among patients hospitalized for worsening heart failure with reduced ejection fraction (from the efficacy of vasopressin antagonism in heart failure outcome study with tolvaptan trial).
    Vaduganathan M; Greene SJ; Ambrosy AP; Mentz RJ; Subacius HP; Chioncel O; Maggioni AP; Swedberg K; Zannad F; Konstam MA; Senni M; Givertz MM; Butler J; Gheorghiade M;
    Am J Cardiol; 2014 Dec; 114(11):1713-21. PubMed ID: 25312638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Worsening depressive symptoms are associated with adverse clinical outcomes in patients with heart failure.
    Sherwood A; Blumenthal JA; Hinderliter AL; Koch GG; Adams KF; Dupree CS; Bensimhon DR; Johnson KS; Trivedi R; Bowers M; Christenson RH; O'Connor CM
    J Am Coll Cardiol; 2011 Jan; 57(4):418-23. PubMed ID: 21251581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble ST2 in ambulatory patients with heart failure: Association with functional capacity and long-term outcomes.
    Felker GM; Fiuzat M; Thompson V; Shaw LK; Neely ML; Adams KF; Whellan DJ; Donahue MP; Ahmad T; Kitzman DW; Piña IL; Zannad F; Kraus WE; O'Connor CM
    Circ Heart Fail; 2013 Nov; 6(6):1172-9. PubMed ID: 24103327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contemporary Characteristics and Outcomes in Chagasic Heart Failure Compared With Other Nonischemic and Ischemic Cardiomyopathy.
    Shen L; Ramires F; Martinez F; Bodanese LC; Echeverría LE; Gómez EA; Abraham WT; Dickstein K; Køber L; Packer M; Rouleau JL; Solomon SD; Swedberg K; Zile MR; Jhund PS; Gimpelewicz CR; McMurray JJV;
    Circ Heart Fail; 2017 Nov; 10(11):. PubMed ID: 29141857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of Ejection Fraction on Outcomes and Efficacy of Sacubitril/Valsartan (LCZ696) in Heart Failure with Reduced Ejection Fraction: The Prospective Comparison of ARNI with ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure (PARADIGM-HF) Trial.
    Solomon SD; Claggett B; Desai AS; Packer M; Zile M; Swedberg K; Rouleau JL; Shi VC; Starling RC; Kozan Ö; Dukat A; Lefkowitz MP; McMurray JJ
    Circ Heart Fail; 2016 Mar; 9(3):e002744. PubMed ID: 26915374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sex-Related Differences in Heart Failure With Preserved Ejection Fraction.
    Dewan P; Rørth R; Raparelli V; Campbell RT; Shen L; Jhund PS; Petrie MC; Anand IS; Carson PE; Desai AS; Granger CB; Køber L; Komajda M; McKelvie RS; O'Meara E; Pfeffer MA; Pitt B; Solomon SD; Swedberg K; Zile MR; McMurray JJV
    Circ Heart Fail; 2019 Dec; 12(12):e006539. PubMed ID: 31813280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Age on Comorbidities and Outcomes in Heart Failure With Reduced Ejection Fraction.
    Regan JA; Kitzman DW; Leifer ES; Kraus WE; Fleg JL; Forman DE; Whellan DJ; Wojdyla D; Parikh K; O'Connor CM; Mentz RJ
    JACC Heart Fail; 2019 Dec; 7(12):1056-1065. PubMed ID: 31779928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serial Assessment of High-Sensitivity Cardiac Troponin and the Effect of Dapagliflozin in Patients With Heart Failure With Reduced Ejection Fraction: An Analysis of the DAPA-HF Trial.
    Berg DD; Docherty KF; Sattar N; Jarolim P; Welsh P; Jhund PS; Anand IS; Chopra V; de Boer RA; Kosiborod MN; Nicolau JC; O'Meara E; Schou M; Hammarstedt A; Langkilde AM; Lindholm D; Sjöstrand M; McMurray JJV; Sabatine MS; Morrow DA
    Circulation; 2022 Jan; 145(3):158-169. PubMed ID: 34743554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical profile and prognostic value of anemia at the time of admission and discharge among patients hospitalized for heart failure with reduced ejection fraction: findings from the EVEREST trial.
    Mentz RJ; Greene SJ; Ambrosy AP; Vaduganathan M; Subacius HP; Swedberg K; Maggioni AP; Nodari S; Ponikowski P; Anker SD; Butler J; Gheorghiade M
    Circ Heart Fail; 2014 May; 7(3):401-8. PubMed ID: 24737459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors related to morbidity and mortality in patients with chronic heart failure with systolic dysfunction: the HF-ACTION predictive risk score model.
    O'Connor CM; Whellan DJ; Wojdyla D; Leifer E; Clare RM; Ellis SJ; Fine LJ; Fleg JL; Zannad F; Keteyian SJ; Kitzman DW; Kraus WE; Rendall D; Piña IL; Cooper LS; Fiuzat M; Lee KL
    Circ Heart Fail; 2012 Jan; 5(1):63-71. PubMed ID: 22114101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CHA2DS2-VASc and ATRIA Scores and Clinical Outcomes in Patients with Heart Failure with Preserved Ejection Fraction.
    Zhu W; Wu Y; Zhou Y; Liang W; Xue R; Wu Z; Dong Y; Liu C
    Cardiovasc Drugs Ther; 2020 Dec; 34(6):763-772. PubMed ID: 32583288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes by race and etiology of patients with left ventricular systolic dysfunction.
    Thomas KL; East MA; Velazquez EJ; Tuttle RH; Shaw LK; O'Connor CM; Peterson ED
    Am J Cardiol; 2005 Oct; 96(7):956-63. PubMed ID: 16188524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.